SCHEMBL8285140

SCHEMBL8285140

COCCNc1cc(C)c2c(=O)cc(Nc3ccc(F)cc3)n(-c3ccc(F)cc3)c2n1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH3 Q9ULD8 3/20 0.44
ALDH1A1 P00352 6/20 0.37
KDM4E B2RXH2 4/20 0.37
MAPT P10636 2/20 0.37
GAA P10253 3/20 0.35
HPGD P15428 3/20 0.35
GLA P06280 1/20 0.35
CASP1 P29466 1/20 0.35
CASP7 P55210 1/20 0.35
ATM Q13315 1/20 0.35
HSD17B10 Q99714 1/20 0.35
LMNA P02545 3/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
MEN1 O00255 1/20 0.35
HTT P42858 1/20 0.35
KMT2A Q03164 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
PDE11A Q9HCR9 1/20 0.35
FYN P06241 1/20 0.34
MKNK1 Q9BUB5 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8286094 0.89 PDE11A (0.45) KCNH3ALDH1A1KDM4EMAPTGAA
SCHEMBL8287107 0.80 PDE11A (0.48) KCNH3ALDH1A1KDM4EMAPTGAA
SCHEMBL8287864 0.79 PDE11A (0.44) KCNH3ALDH1A1KDM4EMAPTGAA
SCHEMBL8287857 0.79 PDE11A (0.56) KCNH3ALDH1A1KDM4EMAPTGAA
SCHEMBL8285185 0.77 CSNK2A2 (0.39) ALDH1A1PDE11ACFTRSMN1; SMN2POLB
SCHEMBL8285186 0.76 ADORA3 (0.37) ALDH1A1KDM4EMAPTGAAHPGD
SCHEMBL8287115 0.76 PDE11A (0.44) KCNH3ALDH1A1KDM4EMAPTGAA
SCHEMBL8286089 0.75 PDE11A (0.45) KCNH3ALDH1A1KDM4EMAPTHPGD
SCHEMBL8287365 0.75 GRM5 (0.38) ALDH1A1KDM4EMAPTGAAMEN1
SCHEMBL8286091 0.75 PDE11A (0.46) KCNH3ALDH1A1CASP1CASP7HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed
WO-2003027112-A1 1, 8-NAPHTHYRIDINE DERIVATIVES AS ANTIDIABETICS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed